Submitted by dcc on Thu, 2017-02-16 13:44 Study Title: Randomized Phase II and Phase III Studies of Individualized Treatment for Nasopharyngeal Carcinoma Based on Biomarker Epstein Barr Virus (EBV) Deoxyribonucleic Acid (DNA)CIRB: Adult CIRB - Late Phase EmphasisLead Group: RTOGStatus: ActiveReview Status: Available to Open
